Early Mortality Predictors in İnfective Endocarditis Patients: A Single-Center Surgical Experience
- PMID: 36259995
- PMCID: PMC9713650
- DOI: 10.21470/1678-9741-2021-0621
Early Mortality Predictors in İnfective Endocarditis Patients: A Single-Center Surgical Experience
Abstract
Introduction: Infective endocarditis is a disease that progresses with morbidity and mortality, afecting 3-10 out of 100,000 people per year. We conducted this study to review the early outcomes of surgical treatment of infective endocarditis.
Methods: In this retrospective study, 122 patients who underwent cardiac surgery for infective endocarditis in our clinic between November 2009 and December 2020 were evaluated. Patients were divided into two groups according to in-hospital mortality. Demographic, echocardiographic, laboratory, operative, and postoperative data of the groups were compared.
Results: Between November 3, 2009, and December 7, 2020, 122 patients were operated for infective endocarditis in our hospital. Emergency surgery was performed in nine (7.3%) patients. In-hospital mortality occurred in 23 (18.9%) patients, and 99 (81.1%) patients were discharged. In-hospital mortality was related with older age, presence of periannular abscess, New York Heart Association class 3 or 4 symptoms, low albumin level, high alanine aminotransferase level, and longer cross-clamping time (P<0.05 for all).
Conclusion: The presence of paravalvular abscess was the most important prognostic factor in patients operated for infective endocarditis.
Keywords: Abscess; Alanine Transaminase; Endocarditis; Hospital Mortality; Mortality; Thoracic Surgery.
Conflict of interest statement
No conflict of interest.
Comment in
-
Letter to the Editor About the Study Titled 'Early Mortality Predictors in Infective Endocarditis Patients: A Single-Center Surgical Experience'.Braz J Cardiovasc Surg. 2023 Jul 4;38(4):e20220419. doi: 10.21470/1678-9741-2022-0419. Braz J Cardiovasc Surg. 2023. PMID: 37403916 Free PMC article. No abstract available.
-
Infective Endocarditis: Controversies and Convictions in the Surgical Treatment.Braz J Cardiovasc Surg. 2023 Oct 5;38(6):e20230014. doi: 10.21470/1678-9741-2023-0014. Braz J Cardiovasc Surg. 2023. PMID: 37797246 Free PMC article. No abstract available.
References
-
- Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40(39):3222–3232. doi: 10.1093/eurheartj/ehz620. Erratum in: Eur Heart J. 2020;41(22):2091. - DOI - PubMed
-
- Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC). Endorsed by: European association for cardio-thoracic surgery (EACTS), the European association of nuclear medicine (EANM) Eur Heart J. 2015;36(44):3075–3128. doi: 10.1093/eurheartj/ehv319. - DOI - PubMed
-
- Papakonstantinou PE, Samonis G, Andrianaki AM, Christofaki M, Dimopoulou D, Papadakis J, et al. Epidemiology, microbiological and clinical features, treatment, and outcomes of infective endocarditis in Crete, Greece. Infect Chemother. 2018;50(1):21–28. doi: 10.3947/ic.2018.50.1.21. - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical